scholarly article | Q13442814 |
P356 | DOI | 10.1378/CHEST.11-0862 |
P698 | PubMed publication ID | 21680645 |
P50 | author | Gregory Lip | Q60393087 |
Jonas Bjerring Olesen | Q78699620 | ||
Deirdre A Lane | Q87919930 | ||
Laurent Fauchier | Q88191651 | ||
P2093 | author name string | Sophie Taillandier | |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
Atrial Fibrillation | Q815819 | ||
thromboembolism | Q891391 | ||
P1104 | number of pages | 7 | |
P304 | page(s) | 147-153 | |
P577 | publication date | 2011-06-16 | |
P1433 | published in | Chest | Q5093377 |
P1476 | title | Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. | |
P478 | volume | 141 |
Q40630376 | A comparison of the CHARGE-AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study |
Q38055506 | A review of the epidemiological profile of patients with atrial fibrillation and heart failure |
Q38185595 | AF Detected on Implanted Cardiac Implantable Electronic Devices: Is There a Threshold for Thromboembolic Risk? |
Q37496271 | AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score |
Q26827113 | Antithrombotic management of atrial fibrillation in the elderly |
Q38065252 | Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease. |
Q38800244 | Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis |
Q37495770 | CHADS2 and CHA2DS2Vasc-Score in Peripheral Systemic Embolism |
Q37975986 | Can we predict stroke in atrial fibrillation? |
Q42318486 | Do we always need anticoagulation before cardioversion of atrial fibrillation in ladies? |
Q44104897 | Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study |
Q49989655 | Heart failure: a weak link in CHA2 DS2 -VASc. |
Q37704200 | Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry |
Q47135508 | Incorporating Stroke and Bleeding Risk Stratification Tools into Atrial Fibrillation Management Making Sense of the Alphabet Soup |
Q38116784 | Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure |
Q43729040 | One-year clinical prediction in Chinese ischemic stroke patients using the CHADS2 and CHA2DS2-VASc scores: the China National Stroke Registry. |
Q58099349 | Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review |
Q51067567 | Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1. |
Q38803355 | Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk |
Q40386721 | Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study |
Q37469069 | Stroke And Bleeding Risk Assessment: Where Are We Now? |
Q90182016 | Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies |
Q38069057 | Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why? |
Q38244278 | Stroke and bleeding risk in atrial fibrillation: navigating the alphabet soup of risk-score acronyms (CHADS2 , CHA2 DS2 -VASc, R2 CHADS2 , HAS-BLED, ATRIA, and more). |
Q38069194 | Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future perspectives |
Q48360646 | The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy |
Q38084661 | The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review |
Q85207443 | The risk stratification in atrial fibrillation |
Q57630432 | Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score |
Q30354838 | Who Needs Pharmacologic Therapy? |
Search more.